ProShares UltraPro QQQ ETF vs 10X Genomics Inc — how do they compare? ProShares UltraPro QQQ ETF trades at $71.45, while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, ProShares UltraPro QQQ ETF nearer its low. Which is the better fit depends on your goals.
| TQQQ | TXG | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $87.22 | $45.80 |
52-Week Low | $37.89 | $11.34 |
Market Cap | — | $5.48B |
Enterprise Value | — | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →